BioStone Animal Health Launches Equine Herpes Virus (EHV) and Equine Viral Arteritis (EVA) ELISA

DALLAS-FORT WORTH, TX— October 3, 2025 — BioStone Animal Health is pleased to announce the launch of two new antibody detection kits designed for the equine market: the AsurDx™ Equine Herpesvirus (EHV) Antibody Test Kit and the AsurDx™ Equine Viral Arteritis (EVA) Antibody Test Kit. These ELISA-based kits provide veterinarians, laboratories, and researchers with rapid, sensitive, and cost-effective tools to monitor antibody responses to two significant equine pathogens.

Equine Herpesvirus (EHV) Antibody Test Kit

Equine herpesviruses are highly contagious and can cause a range of clinical symptoms, including respiratory disease, abortion, neonatal death, and neurologic disorders in horses. The AsurDx™ EHV Antibody Test Kit is designed for the detection of IgG antibodies against EHV in equine serum and plasma samples. The kit offers strong sensitivity and specificity and can be used for large-scale surveillance, diagnostic monitoring, and herd health management. With its straightforward ELISA format, the kit delivers reliable and reproducible results to support disease control efforts.

Equine Viral Arteritis (EVA) Antibody Test Kit

Equine viral arteritis, caused by the Alphaarterivirus equid, is a globally distributed disease of horses. While most infections are subclinical, EVA can cause fever, edema, conjunctivitis, hives, abortion, and pneumonia in foals, with carrier stallions serving as a major reservoir for transmission. The AsurDx™ EVA Antibody Test Kit detects equine IgG antibodies against EVA in serum and plasma, providing a dependable tool for disease surveillance and control programs. Its colorimetric ELISA format allows for sensitive, accurate, and reproducible results in both routine diagnostic and research settings.

About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. By making these test kits available to the international community, BioStone strives to actively promote and participate in global animal health initiatives. For more information about BioStone Animal Health, visit www.biostoneah.com